Results 21 to 30 of about 7,096 (184)

Fahr’s syndrome as a manifestation of autoimmune polyendocrine syndrome-1 and its unusual association with neuromyelitis optica spectrum disorder

Frontiers in Neuroscience, 2023
Fahr’s syndrome, also known as bilateral striopallidodendate calcinosis, is a rare inherited neurodegenerative illness characterized by abnormal calcium deposition in several areas of the brain, resulting in a wide range of neuropsychological symptoms ...
Ahmad Nawaz, Azba Ahmad, Ayesha Aslam, Safia Bano, Ahsan Numan, Eisham Sarmad   +5 more
doaj   +1 more source

Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorders

Journal of Central Nervous System Disease, 2021
Background Neuromyelitis optica spectrum disorders (NMOSDs) are rare antibody-mediated disorders of the central nervous system, with a predilection for the spinal cord and optic nerves.
Otto Jesus Hernandez Fustes MD, PhD, Cláudia S K Kay MD, Paulo José Lorenzoni MD, PhD, Renata D-P Ducci MD, PhD, Lineu C Werneck MD, PhD, Rosana Herminia Scola MD, PhD   +5 more
doaj   +1 more source

Neuromyelitis optica spectrum disorders in pediatric patients

Неврология, нейропсихиатрия, психосоматика, 2018
Neuromyelitis optica spectrum disorders (NMOSDs) is an inflammatory demyelinating disease of the central nervous system with a selective injury of the optic nerves and spinal cord.
Yu. V. Tokareva, A. S. Kotov, M. V. Panteleeva, M. S. Bunak   +3 more
doaj   +1 more source

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders

Неврология, нейропсихиатрия, психосоматика, 2021
Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied by central nervous system damage, widespread immunemediated demyelination, and axonal damage, involving mainly the optic nerves, spinal cord, and area ...
A. N. Boyko, K. Z. Bakhtiyarova, L. V. Brylev, M. N. Zakharova, D. S. Kasatkin, D. S. Korobko, S. V. Kotov, V. S. Krasnov, N. A. Malkova, E. V. Popova, S. A. Sivertseva, T. O. Simaniv, A. A. Sokolova, N. A. Totolyan, T. N. Trushnikova, F. A. Khabirov, N. V. Khachanova   +16 more
doaj   +1 more source

Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy

Неврология, нейропсихиатрия, психосоматика, 2023
In the review, we present the main pathogenetic mechanisms of the development of neuromyelitis optic spectrum disorders (NMOSD) associated with the appearance of anti-aquaporin-4 (APQ4-IgG) autoantibodies: damage to astrocytes, including complement ...
P. A. Zaitseva, A. N. Boyko
doaj   +1 more source

Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis

Neural Regeneration Research
Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction. To date, no effective treatment exists as the exact causative mechanism remains unknown.
Li Xu, Huiming Xu, Changyong Tang
doaj   +1 more source

Late Onset of Neuromyelitis Optica Spectrum Disorders

Neurology and Therapy, 2019
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disease of the central nervous system. NMOSD starting after the age of 50 years is considered a “late onset” (LO-NMOSD) and seems to be particularly aggressive ...
Yara Dadalti Fragoso, Heloisa Helena Ruocco, Ronaldo Maciel Dias, Hideraldo Cabeça, Ricardo Gonçalves, Nise A. de Carvalho Sousa, Caroline Vieira Spessotto, Carlos Bernardo Tauil, Soniza Vieira Alves-Leon, Sidney Gomes, Marcus Vinicius M. Gonçalves, Suzana C. Nunes Machado, Andrea Anacleto, Eber Castro Correa, Maria Lucia V. Pimentel, Gutemberg Augusto C. Santos   +15 more
doaj   +1 more source

Recent developments in MOG-IgG associated neurological disorders

Therapeutic Advances in Neurological Disorders, 2020
In the past few years, acquired demyelinating syndromes of the central nervous system associated with antibodies against myelin oligodendrocyte glycoprotein (MOG) have evolved into a new inflammatory disease entity distinct from neuromyelitis optica ...
Harald Hegen, Markus Reindl
doaj   +1 more source

Research progress of neuroregeneration in neuromyelitis optica spectrum disorders

Chinese Journal of Contemporary Neurology and Neurosurgery, 2022
In the treatment of neurological diseases, neuroregeneration is a contentious and challenging issue. Our understanding of the mechanisms related to neuroregeneration in neuromyelitis optica spectrum disorders (NMOSDs) is currently restricted and there ...
QIU Wei , LUO Wen⁃jing
doaj   +1 more source

Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56) [PDF]

Neurology Letters, 2023
Neuromyelitis optica spectrum disorders (NMOSD) is an autoimmune astrocytopathy. The term NMOSD is used as an umbrella term that refers to Aquaporin-4 (IgG) positive NMO and some closely related clinical syndromes without AQP4-IgG. Core clinical features
Maryam Poursadeghfard
doaj